13F filing recap · Q1 2020

What did Chou Associates buy in Q1 2020?

Reported stock-position changes between this filing and the previous one.

Stock value

$99.92M

Positions

Estimated turnover

5.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Reduced positions

BHCBausch Health Companies Inc.$24.16Mreported value-60.0K shares-3.7%JPMJPMorgan Chase & Co$3.09Mreported value-10.0K shares-22.6%DVADaVita Inc.$2.49Mreported value-68.0K shares-67.5%BACBank of America Corp$390.0Kreported value-10.0K shares-35.2%